| 0 (0%) | 09-27 09:29 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 28.57 | 1-year : | 28.91 |
| Resists | First : | 24.46 | Second : | 24.76 |
| Pivot price | 24.23 |
|||
| Supports | First : | 23.97 | Second : | 19.95 |
| MAs | MA(5) : | 24.2 |
MA(20) : | 24.21  |
| MA(100) : | 23.94 |
MA(250) : | 23.78 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 13.4 |
D(3) : | 24.2 |
| RSI | RSI(14): 43.9 |
|||
| 52-week | High : | 24.85 | Low : | 22.84 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ IBD ] has closed below the lower bollinger band by 11.5%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ IBD ] is to continue within current trading range. Bollinger Bands are 27% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 24.18 - 24.37 | 24.37 - 24.51 |
| Low: | 23.66 - 23.88 | 23.88 - 24.03 |
| Close: | 23.82 - 24.16 | 24.16 - 24.39 |
Sat, 27 Sep 2025
This Underrated Spice Seriously Supports The Gut (Even Among Those With IBD) - MindBodyGreen
Fri, 26 Sep 2025
DoorDash, IBD Stock Of The Day, Battles For Grocery Market With Amazon, Uber, Instacart - Investor's Business Daily
Fri, 26 Sep 2025
Recent Developments in Crohn's Disease - MedPage Today
Thu, 25 Sep 2025
IBD and MarketWatch’s sixth annual survey honors most trusted financial companies - MarketWatch
Thu, 25 Sep 2025
AI-Powered Tool to Revolutionize Dietary Management of IBD - AZoRobotics
Tue, 23 Sep 2025
New $10 million initiative aims to tailor diets for Canadians living with IBD - News-Medical
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|